Jump Financial, LLC Gamida Cell Ltd. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.2 - $4.46 $51,480 - $104,364	-23,400 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.85 - $6.44 $20,020 - $33,488	-5,200 Reduced 18.18%	23,400 $92,000
Q2 2021 Aug 13, 2021	BUY	$5.85 - $8.33 $46,367 - $66,023	7,926 Added 38.34%	28,600 $183,000
Q1 2021 May 17, 2021	BUY	$7.8 - $12.43 $161,257 - $256,977	20,674 New	20,674 $167,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.